RxDoctor Payments Data

Patrick Sutphin, MD

Vascular & Interventional Radiology · Dallas, TXNPI 1982809588

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Boston Scientific at 30.7% of the total. 2025 is the largest year on record at $3,784, more than ten times the $350 reported in 2022.

$7,137in general payments, 2019–2025

Across 38 payments — averaging $187.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Penumbra, Inc.$1K
  • Delcath Systems$1K
  • Trisalus Life Sciences, Inc.$888
  • Sirtex Medical Inc$737
  • Instylla, Inc.$182
  • plus $895 from 6 others
$339,294in research payments, 2019–2025

Across 5 payments — averaging $67,859 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Trisalus Life Sciences, Inc.$290K
  • Siemens Medical Solutions USA, Inc.$30K
  • Instylla, Inc.$19K

What the payments were for

  • Consulting fees$90013%
  • Travel & lodging$2,71638%
  • Food & beverage$3,52149%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,137 in reported general payments places this provider in the 70th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas

Medicare billing

Part B allowed, 2024
$70,079
Medicare patients
236
Services billed
881

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →